Sight Sciences (SGHT) News Today $2.83 -0.01 (-0.35%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Citi Remains a Hold on Sight Sciences (SGHT)January 17 at 7:28 PM | markets.businessinsider.comSight Sciences price target lowered to $3 from $5 at Lake StreetJanuary 16 at 8:35 AM | markets.businessinsider.comNeedham & Company LLC Reiterates Hold Rating for Sight Sciences (NASDAQ:SGHT)January 16 at 3:51 AM | americanbankingnews.comExpert Outlook: Sight Sciences Through The Eyes Of 5 AnalystsJanuary 15, 2025 | benzinga.comLake Street Capital Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $3.00Lake Street Capital decreased their target price on Sight Sciences from $5.00 to $3.00 and set a "hold" rating for the company in a research note on Wednesday.January 15, 2025 | marketbeat.comSight Sciences (SGHT) Receives a Hold from NeedhamJanuary 15, 2025 | markets.businessinsider.comStifel Nicolaus Sticks to Their Buy Rating for Sight Sciences (SGHT)January 15, 2025 | markets.businessinsider.comSight Sciences (NASDAQ:SGHT) Earns "Hold" Rating from Needham & Company LLCNeedham & Company LLC reaffirmed a "hold" rating on shares of Sight Sciences in a report on Tuesday.January 14, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) CTO Sells $12,482.54 in StockJanuary 11, 2025 | insidertrades.comInsider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells 3,829 Shares of StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) CTO David Badawi sold 3,829 shares of Sight Sciences stock in a transaction on Wednesday, January 8th. The stock was sold at an average price of $3.26, for a total transaction of $12,482.54. Following the sale, the chief technology officer now owns 1,749,541 shares in the company, valued at $5,703,503.66. This represents a 0.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.January 10, 2025 | marketbeat.comSight Sciences study demonstrates benefits of OMNI system for managing POAGJanuary 8, 2025 | markets.businessinsider.comSight Sciences, Inc. (NASDAQ:SGHT) CTO David Badawi Sells 3,111 SharesJanuary 7, 2025 | insidertrades.comInsider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells 3,111 Shares of StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) CTO David Badawi sold 3,111 shares of the stock in a transaction dated Friday, January 3rd. The stock was sold at an average price of $3.52, for a total transaction of $10,950.72. Following the sale, the chief technology officer now owns 1,753,370 shares of the company's stock, valued at $6,171,862.40. This trade represents a 0.18 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.January 6, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $17,121.28 in StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) insider Jeremy B. Hayden sold 4,864 shares of Sight Sciences stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $3.52, for a total transaction of $17,121.28. Following the completion of the sale, the insider now owns 153,823 shares in the company, valued at approximately $541,456.96. This represents a 3.07 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.January 6, 2025 | marketbeat.comInsider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CEO Sells 12,236 Shares of StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) CEO Paul Badawi sold 12,236 shares of the company's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $3.60, for a total value of $44,049.60. Following the sale, the chief executive officer now directly owns 5,713,197 shares in the company, valued at $20,567,509.20. This trade represents a 0.21 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.January 6, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Given Average Rating of "Hold" by BrokeragesSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) has been given an average rating of "Hold" by the six research firms that are presently covering the stock, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendationDecember 31, 2024 | marketbeat.comLake Street Issues a Hold Rating on Sight Sciences (SGHT)December 22, 2024 | markets.businessinsider.comSight Sciences does BIA of TearCare to treat MGD-associated DED in USDecember 21, 2024 | markets.businessinsider.comSight Sciences Announces the Results of a Budget Impact Analysis for its TearCare® System for the Treatment of Meibomian Gland Disease (“MGD”) Showing Cost Savings Over Existing Reimbursed Treatment OptionsDecember 19, 2024 | globenewswire.comSight Sciences price target lowered to $4.60 from $5.80 at CitiDecember 11, 2024 | markets.businessinsider.comSight Sciences, Inc. (NASDAQ:SGHT) EVP Buys $19,250.00 in StockDecember 10, 2024 | insidertrades.comUBS Initiates Coverage of Sight Sciences (SGHT) with Buy RecommendationDecember 7, 2024 | msn.comPromising Growth Prospects for Sight Sciences Driven by TearCare and OMNI SolutionsDecember 6, 2024 | markets.businessinsider.comSight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Recommendation of "Hold" from AnalystsSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) has been given a consensus recommendation of "Hold" by the six research firms that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. TheDecember 6, 2024 | marketbeat.comManohar K. Raheja Buys 3,376 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) StockDecember 6, 2024 | insidertrades.comSight Sciences (NASDAQ:SGHT) Coverage Initiated at UBS GroupUBS Group began coverage on shares of Sight Sciences in a report on Friday. They set a "buy" rating and a $5.50 price objective for the company.December 6, 2024 | marketbeat.comManohar K. Raheja Purchases 4,624 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) StockDecember 4, 2024 | insidertrades.comSight Sciences assumed with an Equal Weight at Morgan StanleyDecember 3, 2024 | markets.businessinsider.comMillrace Asset Group Inc. Acquires New Shares in Sight Sciences, Inc. (NASDAQ:SGHT)Millrace Asset Group Inc. bought a new stake in shares of Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 138,793 shares of the company's stock, valuedNovember 26, 2024 | marketbeat.comSight sciences EVP Manohar Raheja acquires $7,400 in stockNovember 23, 2024 | uk.investing.comSight Sciences director Encrantz sells $2.06 million in stockNovember 23, 2024 | investing.comSight Sciences to Present at the Piper Sandler 36th Annual Healthcare ConferenceNovember 19, 2024 | globenewswire.comWilliam Blair Expects Increased Earnings for Sight SciencesSight Sciences, Inc. (NASDAQ:SGHT - Free Report) - Research analysts at William Blair raised their FY2024 earnings per share (EPS) estimates for shares of Sight Sciences in a research report issued on Monday, November 11th. William Blair analyst M. Andrew now forecasts that the company will postNovember 13, 2024 | marketbeat.comSight Sciences price target lowered to $5 from $7 at Morgan StanleyNovember 11, 2024 | markets.businessinsider.comMorgan Stanley Issues Pessimistic Forecast for Sight Sciences (NASDAQ:SGHT) Stock PriceMorgan Stanley dropped their target price on shares of Sight Sciences from $7.00 to $5.00 and set an "equal weight" rating on the stock in a research note on Monday.November 11, 2024 | marketbeat.com'A direct relationship between your sense of sight and recovery rate': Biologist Kathy Willis on why looking at nature can speed up healingNovember 10, 2024 | msn.comSight Sciences Reports Modest Growth and Optimistic OutlookNovember 9, 2024 | markets.businessinsider.comSight Sciences price target lowered to $5.50 from $6 at Piper SandlerNovember 9, 2024 | markets.businessinsider.comSight Sciences, Inc. (SGHT) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comSight Sciences Inc (SGHT) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...November 8, 2024 | finance.yahoo.comSight Sciences (NASDAQ:SGHT) Earns Neutral Rating from Piper SandlerPiper Sandler reissued a "neutral" rating and set a $5.50 price objective (down from $6.00) on shares of Sight Sciences in a research note on Friday.November 8, 2024 | marketbeat.comSight Sciences' (SGHT) "Hold" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC reaffirmed a "hold" rating on shares of Sight Sciences in a report on Friday.November 8, 2024 | marketbeat.comSight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense GuidanceNovember 8, 2024 | markets.businessinsider.comSight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, OperationsNovember 8, 2024 | finance.yahoo.comSight Sciences downgraded to Hold from Buy at Lake StreetNovember 5, 2024 | markets.businessinsider.comSight Sciences (NASDAQ:SGHT) Downgraded to Hold Rating by Lake Street CapitalLake Street Capital cut Sight Sciences from a "buy" rating to a "hold" rating and reduced their price target for the company from $10.00 to $5.00 in a research report on Monday.November 4, 2024 | marketbeat.comMatthew Link Sells 21,831 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) StockOctober 22, 2024 | insidertrades.comSight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $122,471.91 in StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) insider Matthew Link sold 21,831 shares of the company's stock in a transaction that occurred on Monday, October 21st. The shares were sold at an average price of $5.61, for a total value of $122,471.91. Following the completion of the transaction, the insider now directly owns 663,550 shares of the company's stock, valued at $3,722,515.50. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.October 21, 2024 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Insider Matthew Link Sells 20,734 SharesOctober 19, 2024 | insidertrades.comSight Sciences to Report Third Quarter Financial Results on November 7, 2024October 17, 2024 | globenewswire.com Get Sight Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter. Email Address SGHT Media Mentions By Week SGHT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGHT News Sentiment▼0.040.41▲Average Medical News Sentiment SGHT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGHT Articles This Week▼122▲SGHT Articles Average Week Get Sight Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies KIDS News TMCI News SMLR News NNOX News CLPT News TCMD News DCTH News ZIMV News CVRX News NPCE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGHT) was last updated on 1/19/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sight Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sight Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SGHT Stock Alerts